scholarly journals Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance

2021 ◽  
Vol 22 (14) ◽  
pp. 7249
Author(s):  
Siyer Roohani ◽  
Frank Tacke

The liver is an essential immunological organ due to its gatekeeper position to bypassing antigens from the intestinal blood flow and microbial products from the intestinal commensals. The tissue-resident liver macrophages, termed Kupffer cells, represent key phagocytes that closely interact with local parenchymal, interstitial and other immunological cells in the liver to maintain homeostasis and tolerance against harmless antigens. Upon liver injury, the pool of hepatic macrophages expands dramatically by infiltrating bone marrow-/monocyte-derived macrophages. The interplay of the injured microenvironment and altered macrophage pool skews the subsequent course of liver injuries. It may range from complete recovery to chronic inflammation, fibrosis, cirrhosis and eventually hepatocellular cancer. This review summarizes current knowledge on the classification and role of hepatic macrophages in the healthy and injured liver.

2019 ◽  
Vol 116 (13) ◽  
pp. 6162-6171 ◽  
Author(s):  
Yanbo Wang ◽  
Hongwei Liang ◽  
Fangfang Jin ◽  
Xin Yan ◽  
Guifang Xu ◽  
...  

Hepatic injury is often accompanied by pulmonary inflammation and tissue damage, but the underlying mechanism is not fully elucidated. Here we identify hepatic miR-122 as a mediator of pulmonary inflammation induced by various liver injuries. Analyses of acute and chronic liver injury mouse models confirm that liver dysfunction can cause pulmonary inflammation and tissue damage. Injured livers release large amounts of miR-122 in an exosome-independent manner into the circulation compared with normal livers. Circulating miR-122 is then preferentially transported to mouse lungs and taken up by alveolar macrophages, in which it binds Toll-like receptor 7 (TLR7) and activates inflammatory responses. Depleting miR-122 in mouse liver or plasma largely abolishes liver injury-induced pulmonary inflammation and tissue damage. Furthermore, alveolar macrophage activation by miR-122 is blocked by mutating the TLR7-binding GU-rich sequence on miR-122 or knocking out macrophage TLR7. Our findings reveal a causative role of hepatic miR-122 in liver injury-induced pulmonary dysfunction.


Hepatology ◽  
1993 ◽  
Vol 17 (6) ◽  
pp. 1086-1094 ◽  
Author(s):  
Fukashi Doi ◽  
Tomomochi Goya ◽  
Motomichi Torisu

2021 ◽  
Vol 12 ◽  
Author(s):  
Ziheng Yang ◽  
Jie Zhang ◽  
Yan Wang ◽  
Jing Lu ◽  
Quan Sun

Polarization of hepatic macrophages plays a crucial role in the injury and repair processes of acute and chronic liver diseases. However, the underlying molecular mechanisms remain elusive. Caveolin-1 (Cav1) is the structural protein of caveolae, the invaginations of the plasma membrane. It has distinct functions in regulating hepatitis, cirrhosis, and hepatocarcinogenesis. Given the increasing number of cases of liver cancer, nonalcoholic steatohepatitis, and non-alcoholic fatty liver disease worldwide, investigations on the role of Cav1 in liver diseases are warranted. In this study, we aimed to investigate the role of Cav1 in the pathogenesis of acute liver injury. Wild-type (WT) and Cav1 knockout (KO) mice (Cav1tm1Mls) were injected with carbon tetrachloride (CCl4). Cav1 KO mice showed significantly reduced degeneration, necrosis, and apoptosis of hepatocytes and decreased level of alanine transaminase (ALT) compared to WT mice. Moreover, Cav1 was required for the recruitment of hepatic macrophages. The analysis of the mRNA levels of CD86, tumor necrosis factor (TNF), and interleukin (IL)-6, as well as the protein expression of inducible nitric oxide synthase (iNOS), indicated that Cav1 deficiency inhibited the polarization of hepatic macrophages towards the M1 phenotype in the injured liver. Consistent with in vivo results, the expressions of CD86, TNF, IL-6, and iNOS were significantly downregulated in Cav1 KO macrophages. Also, fluorescence-activated cell sorting (FACS) analysis showed that the proportion of M1 macrophages was significantly decreased in the liver tissues obtained from Cav1 KO mice following CCl4 treatment. In summary, our results showed that Cav1 deficiency protected mice against CCl4-induced acute liver injury by regulating polarization of hepatic macrophages. We provided direct genetic evidence that Cav1 expressed in hepatic macrophages contributed to the pathogenesis of acute liver injury by regulating the polarization of hepatic macrophages towards the M1 phenotype. These findings suggest that Cav1 expressed in macrophages may represent a potential therapeutic target for acute liver injury.


2021 ◽  
Vol 22 (12) ◽  
pp. 6429
Author(s):  
Xia Xu ◽  
Shuyu Liu ◽  
Hua Liu ◽  
Kang Ru ◽  
Yunxian Jia ◽  
...  

Piezo channels are mechanosensitive ion channels located in the cell membrane and function as key cellular mechanotransducers for converting mechanical stimuli into electrochemical signals. Emerged as key molecular detectors of mechanical forces, Piezo channels’ functions in bone have attracted more and more attention. Here, we summarize the current knowledge of Piezo channels and review the research advances of Piezo channels’ function in bone by highlighting Piezo1′s role in bone cells, including osteocyte, bone marrow mesenchymal stem cell (BM-MSC), osteoblast, osteoclast, and chondrocyte. Moreover, the role of Piezo channels in bone diseases is summarized.


eLife ◽  
2018 ◽  
Vol 7 ◽  
Author(s):  
Yasushi Miura ◽  
Satoshi Matsui ◽  
Naoko Miyata ◽  
Kenichi Harada ◽  
Yamato Kikkawa ◽  
...  

Under chronic or severe liver injury, liver progenitor cells (LPCs) of biliary origin are known to expand and contribute to the regeneration of hepatocytes and cholangiocytes. This regeneration process is called ductular reaction (DR), which is accompanied by dynamic remodeling of biliary tissue. Although the DR shows apparently distinct mode of biliary extension depending on the type of liver injury, the key regulatory mechanism remains poorly understood. Here, we show that Lutheran (Lu)/Basal cell adhesion molecule (BCAM) regulates the morphogenesis of DR depending on liver disease models. Lu+ and Lu- biliary cells isolated from injured liver exhibit opposite phenotypes in cell motility and duct formation capacities in vitro. By overexpression of Lu, Lu- biliary cells acquire the phenotype of Lu+ biliary cells. Lu-deficient mice showed severe defects in DR. Our findings reveal a critical role of Lu in the control of phenotypic heterogeneity of DR in distinct liver disease models.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 2518-2518
Author(s):  
Masahiro Masuya ◽  
Hiroto Araki ◽  
Kohshi Ohishi ◽  
Naoyuki Katayama

Abstract Abstract 2518 Poster Board II-495 Objective: It has been known that hepatic stellate cells (HpSCs) play an important role in the development of liver fibrosis. We previously reported that the HpSCs are hematopoietic origin in carbon tetrachloride (CCl4)-induced liver injury. However, the differentiation pathway from hematopoietic stem cells to HpSCs remains largely unknown. In this study, we tried to elucidate the ability of terminally differentiated cells to transdifferentiate into HpSCs. Methods: Male enhanced green fluorescent protein (EGFP)-transgenic mice 10–12 weeks old were used as bone marrow and spleen donors. Bone marrow mononuclear cells were incubated with purified anti-CD45R/B220, anti-CD4, anti-CD8, anti-Ly6G, anti-TER119, anti-c-kit, anti-Sca-1, anti-Thy-1.2, anti-IL-7 receptor α chain, and immunomagnetic beads. The resulting lineage negative cells were stained with anti-Ly6C, anti-c-kit, and anti-CD45.2. CD45.2+Ly6Clowc-kit+ cells (monocytic precursors), CD45.2+Ly6Chighc-kit− cells (mature monocytes), FSClowSSChigh CD45.2+ cells (eosinophils) were enriched by FACSAria. Ly6G+ cells (neutrophils), CD45R/B220+ cells (B cells) and CD3ε+ cells (T cells) were isolated from bone marrow or spleen using magnetic cell sorter device. We transferred these isolated cells into CCl4-injured mice twice a week for two weeks, and analyzed the presence of EGFP+ HpSCs in the injured liver using immunofluorescence and laser confocal scanning microscopy. Results: Total number of transfused monocytic precursors, mature monocytes, eosinophils, neutrophils, B cells, and T cells per mouse was 1.1 × 106, 6.4 × 106, 4.8 × 106, 22.0 × 106, 29.0 × 106, and 12.5 × 106, respectively. Intravenous infusion of each type of cell showed their ability to localize to the injured liver. In the liver of mice, which were given eosinophils, neutrophils, B cells, and T cells, EGFP+ cells were all positive for CD45. However, in the liver of mice, which received monocyte precursors and mature monocytes, 20% and 39% of EGFP+ cells were negative for CD45. Vimentin and ADAMTS13 are identified in HpSCs but not hematopoietic cells. About 18% of EGFP+ cells in the liver of mice, which received monocytic precursors, were positive for both antigens. In the liver of mice, which received mature monocytes, 35% and 27% of EGFP+ cells were positive for vimentin and ADAMTS13, respectively. Conclusion: Both Ly6Clowc-kit+ monocytic precursors and Ly6Chighc-kit− mature monocytes can give rise to HpSCs in CCl4-injured liver. Disclosures: No relevant conflicts of interest to declare.


Biology ◽  
2020 ◽  
Vol 9 (7) ◽  
pp. 157
Author(s):  
Kun-Yu Teng ◽  
Juan M. Barajas ◽  
Peng Hu ◽  
Samson T. Jacob ◽  
Kalpana Ghoshal

MicroRNA-122 (miR-122) has been identified as a marker of various liver injuries, including hepatitis- virus-infection-, alcoholic-, and non-alcoholic steatohepatitis (NASH)-induced liver fibrosis. Here, we report that the extracellular miR-122 from hepatic cells can be delivered to hepatic stellate cells (HSCs) to modulate their proliferation and gene expression. Our published Argonaute crosslinking immunoprecipitation (Ago-CLIP) data identified several pro-fibrotic genes, including Ctgf, as miR-122 targets in mice livers. However, treating Ctgf as a therapeutic target failed to rescue the fibrosis developed in the miR-122 knockout livers. Alternatively, we compared the published datasets of human cirrhotic livers and miR-122 KO livers, which revealed upregulation of BCL2, suggesting its potential role in regulating fibrosis. Notably, ectopic miR-122 expression inhibited BCL2 expression in human HSC (LX-2) cells). Publicly available ChIP-seq data in human hepatocellular cancer (HepG2) cells and mice livers suggested miR-122 could regulate BCL2 expression indirectly through c-MYC, which was confirmed by siRNA-mediated depletion of c-MYC in Hepatocellular Carcinoma (HCC) cell lines. Importantly, Venetoclax, a potent BCL2 inhibitor approved for the treatment of leukemia, showed promising anti-fibrotic effects in miR-122 knockout mice. Collectively, our data demonstrate that miR-122 suppresses liver fibrosis and implicates anti-fibrotic potential of Venetoclax.


Nutrients ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 1326
Author(s):  
Andrea Mega ◽  
Luca Marzi ◽  
Michael Kob ◽  
Andrea Piccin ◽  
Annarosa Floreani

The liver is an important organ and plays a key role in the regulation of metabolism and in the secretion, storage, and detoxification of endogenous and exogenous substances. The impact of food and nutrition on the pathophysiological mechanisms of liver injury represents a great controversy. Several environmental factors including food and micronutrients are involved in the pathogenesis of liver damage. Conversely, some xenobiotics and micronutrients have been recognized to have a protective effect in several liver diseases. This paper offers an overview of the current knowledge on the role of xenobiotics and micronutrients in liver damage.


2019 ◽  
Vol 2019 ◽  
pp. 1-12 ◽  
Author(s):  
Juçara Gastaldi Cominal ◽  
Maira da Costa Cacemiro ◽  
Belinda Pinto-Simões ◽  
Hans-Jochem Kolb ◽  
Kelen Cristina Ribeiro Malmegrim ◽  
...  

Homoeostasis of bone marrow microenvironment depends on a precise balance between cell proliferation and death, which is supported by the cellular-extracellular matrix crosstalk. Multipotent mesenchymal stromal cells (MSC) are the key elements to provide the specialized bone marrow microenvironment by supporting, maintaining, and regulating the functions and fate of haematopoietic stem cells. Despite the great potential of MSC for cell therapy in several diseases due to their regenerative, immunomodulatory, and anti-inflammatory properties, they can also contribute to modulate tumor microenvironment. The extracellular vesicles that comprise exosomes and microvesicles are important mediators of intercellular communication due to their ability to change phenotype and physiology of different cell types. These vesicles may interact not only with neighbouring cells but also with cells from distant tissues to either maintain tissue homoeostasis or participate in disease pathogenesis. This review focuses on the current knowledge about the physiological role of MSC-extracellular vesicles, as well as their deregulation in haematological malignancies and their potential applications as biomarkers for diagnosis, progression, and treatment monitoring of such diseases.


2021 ◽  
Vol 22 (3) ◽  
pp. 1026
Author(s):  
Mireia Uribe-Herranz ◽  
Nela Klein-González ◽  
Luis Gerardo Rodríguez-Lobato ◽  
Manel Juan ◽  
Carlos Fernández de Larrea

Hematological malignancies, including multiple myeloma, lymphoma, and leukemia, are a heterogeneous group of neoplasms that affect the blood, bone marrow, and lymph nodes. They originate from uncontrolled growth of hematopoietic and lymphoid cells from different stages in their maturation/differentiation and account for 6.5% of all cancers around the world. During the last decade, it has been proven that the gut microbiota, more specifically the gastrointestinal commensal bacteria, is implicated in the genesis and progression of many diseases. The immune-modulating effects of the human microbiota extend well beyond the gut, mostly through the small molecules they produce. This review aims to summarize the current knowledge of the role of the microbiota in modulating the immune system, its role in hematological malignancies, and its influence on different therapies for these diseases, including autologous and allogeneic stem cell transplantation, chemotherapy, and chimeric antigen receptor T cells.


Sign in / Sign up

Export Citation Format

Share Document